- Dual inhibition of angiotensin converting enzyme and neutral endopept…
Number of the records: 1  

Dual inhibition of angiotensin converting enzyme and neutral endopeptidase produces effective blood pressure control in spontaneously hypertensive rats

  1. SYSr036988
    LBL
      
    ^^^^^naa--2200000-a-4500
    005
      
    20250607120519.3
    008
      
    060327c2005----xo-----e------------engo-
    040
      
    $a BA006 $b slo
    041
    0-
    $a eng $b eng
    044
      
    $a xo $c SK
    080
      
    $a 616.12-008.331.1-085:615.225.2.015.2 $2 2.
    242
    10
    $a Duálna inhibícia enzýmu konvertujúceho angiotenzín a neutrálnej endopeptidázy privodí efektívnu kontrolu krvného tlaku u spontánne hypertenzívnych potkanov $y slo
    245
    10
    $a Dual inhibition of angiotensin converting enzyme and neutral endopeptidase produces effective blood pressure control in spontaneously hypertensive rats / $c E. Kostova ... [et al.]
    300
      
    $b Obr., tab.
    504
      
    $a Res. angl.
    504
      
    $a Bibliogr. odkazy
    650
    12
    $7 sllk_us_auth*d006973 $a hypertenzia $x farmakoterapia $2 mesh $9 .
    650
    12
    $7 sllk_us_auth*d000806 $a ACE inhibítory $x krv $x farmakológia $x farmakokinetika $9 . $2 mesh
    650
    12
    $7 sllk_us_auth*d011480 $a inhibítory proteáz $x krv $x farmakológia $x farmakokinetika $2 mesh $9 .
    650
    22
    $7 sllk_us_auth*d004359 $a farmakoterapia kombinovaná $2 mesh $9 .
    650
    22
    $7 sllk_us_auth*d001794 $a tlak krvný $x účinky liekov $2 mesh $9 .
    650
    22
    $7 sllk_us_auth*d004195 $a modely chorôb u zvierat $2 mesh $9 .
    650
    22
    $7 sllk_us_auth*d051381 $a potkany $2 mesh $9 C
    653
    2-
    $a omapatrilát
    653
    2-
    $a candoxatril
    653
    2-
    $a enalapril
    700
    1-
    $7 sllk_us_auth*p0033923 $a Kostova, E. $u Department of preclinical and clinical pharmacology and toxicology, Medical faculty, Skopje, Republic of Macedonia $4 aut
    700
    1-
    $7 sllk_us_auth*p0033924 $a Jovanoska, E. $u Department of preclinical and clinical pharmacology and toxicology, Medical faculty, Skopje, Republic of Macedonia $4 aut
    700
    1-
    $7 sllk_us_auth*p0044276 $a Zafirov, D. $u Department of preclinical and clinical pharmacology and toxicology, Medical faculty, Skopje, Republic of Macedonia $4 aut
    700
    1-
    $7 sllk_us_auth*p0044277 $a Jakovski, K. $u Medical Faculty, Skopje, Republic of Macedonia $4 aut
    700
    1-
    $7 sllk_us_auth*p0044278 $a Maleska, V. $u Medical Faculty, Skopje, Republic of Macedonia $4 aut
    700
    1-
    $7 sllk_us_auth*p0033921 $a Slaninka-Miceska, M. $u Department of preclinical and clinical pharmacology and toxicology, Medical faculty, Skopje, Republic of Macedonia $4 aut
    773
    0-
    $7 nnas $w sllk_us_cat*sg000135_2005_005_012 $t Bratislavské lekárske listy $g Vol. 106, no. 12 (2005), s. 407-411 $x 0006-9248 $d Bratislava : Slovak Academic Press
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.